Metastatic Renal Cell Carcinoma
Links shared publicly online about this topic
An Update On Targeted Therapy In Metastatic Renal Cell Carcinoma
medicalnewstoday.com — “UroToday.com - For many years the mainstay of treatment for metastatic renal cell carcinoma (RCC) was immunotherapy, with response rates of from 10% to 20%. An improved understanding of the molec” View full resource at medicalnewstoday.com
Most Recently Shared on August 2, 2010 at 7:37 pm By:
An Update On Targeted Therapy In Metastatic Renal Cell Carcinoma UroToday.com - For many years the mainstay of treatmen.. http://dld.bz/pSsc
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
jnci.oxfordjournals.org — “Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib” View full resource at jnci.oxfordjournals.org
Most Recently Shared on May 5, 2011 at 2:00 am By:
Michael Fisch Physician, Doctor, Internist, Pain Medicine Physician, and Oncologist
Hypertension as biomarker for treatment efficacy? JNCI: sunitinib data in renal cell #cancer, http://ow.ly/4Nukp, #cardiac #heart
ingentaconnect Systemic Therapies for Metastatic Renal Cell Carcinoma in Older A...
ingentaconnect.com — “ingentaconnect Systemic Therapies for Metastatic Renal Cell Carcinoma in Older A...” View full resource at ingentaconnect.com
Most Recently Shared on August 8, 2011 at 2:02 pm By:
Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults: (Source: Drugs) http://bit.ly/naH2XX
Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is
urotoday.com — “Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is” View full resource at urotoday.com
Most Recently Shared on May 28, 2010 at 12:09 am By:
Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is… http://goo.gl/fb/3tYBL
Oncology News - Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma |3990985
mdlinx.com — “Oncology Medical Article: Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 1:58 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma: BMC Urology http://t.co/1xFlY2Zw #oncology
Novel Immunotherapy Shows Promise for Metastatic Renal Cell Carcinoma - Renal and Urology News
renalandurologynews.com — “John Schieszer reports that a Phase II study of 25 patients with newly diagnosed metastatic, clear cell, renal cell carcinoma is now suggesting that immunotherapy may be beneficial.” View full resource at renalandurologynews.com
Most Recently Shared on October 4, 2010 at 4:15 am By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Novel Immunotherapy Shows Promise for Metastatic Renal Cell Carcinoma: John Schieszer reports that a Phase II stud... http://bit.ly/avB9F3
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma | http://tinyurl.com/mdlamm
nature.com — “Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma | http://tinyurl.com/mdlamm” View full resource at nature.com
Most Recently Shared on July 1, 2009 at 3:26 pm By:
Kidney Cancer Health Executive
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma | http://tinyurl.com/mdlamm
Sunitinib rechallenge benefited select metastatic renal cell carcinomas | HemOncToday
hemonctoday.com — “Sunitinib rechallenge benefited select metastatic renal cell carcinomas | HemOncToday” View full resource at hemonctoday.com
Most Recently Shared on March 9, 2010 at 7:05 pm By:
HemOnc Today Oncology and Health News
Sunitinib rechallenge benefited select metastatic renal cell carcinomas http://ow.ly/1gczH #ASCOGU #oncology
Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma --" JCO
jco.ascopubs.org — “Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma --" JCO” View full resource at jco.ascopubs.org
Most Recently Shared on July 30, 2009 at 2:19 pm By:
Kidney Cancer Health Executive
Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma http://bit.ly/SVyg1
Beyond the Abstract - An update on targeted therapy in metastatic renal cell carcinoma, by ...: BERKELEY, CA (UroT...
urotoday.com — “Beyond the Abstract - An update on targeted therapy in metastatic renal cell carcinoma, by ...: BERKELEY, CA (UroT...” View full resource at urotoday.com
Most Recently Shared on July 22, 2010 at 12:33 pm By:
Urology & Nephrology OW Health
Beyond the Abstract - An update on targeted therapy in metastatic renal cell carcinoma, by ...: BERKELEY, CA (UroT... http://bit.ly/asHeM8
Defining risk status in the first-line treatment of metastatic renal cell carcinoma - Abstract: Department of Medi...
urotoday.com — “Defining risk status in the first-line treatment of metastatic renal cell carcinoma - Abstract: Department of Medi...” View full resource at urotoday.com
Most Recently Shared on June 2, 2010 at 11:12 pm By:
Urology & Nephrology OW Health
Defining risk status in the first-line treatment of metastatic renal cell carcinoma - Abstract: Department of Medi... http://bit.ly/b7aYjd
Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
clincancerres.aacrjournals.org — “Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on August 11, 2011 at 3:58 pm By:
Kidney Cancer Health Executive
Your doctor can access the Kidney Cancer Risk Score Calculator developed through this international project that... http://fb.me/18w5DMHit
Phase 3 study of axitinib for the treatment of metastatic renal cell carcinoma (mRCC) - MPR
empr.com — “Pfizer announced results from its Phase 3 study of axitinib for the treatment of metastatic renal cell carcinoma (mRCC) in previously treated patients.” View full resource at empr.com
Most Recently Shared on November 19, 2010 at 4:11 pm By:
MPR News: Phase 3 study of axitinib for the treatment of metastatic renal cell carcinoma (mRCC): Pfizer announce... http://bit.ly/9tK4Es
Phase 2 study of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC) - MPR
empr.com — “Argos Therapeutics announced results from its Phase 3 study of AGS-003 in combination with sunitinib for the treatment of metastatic renal cell carcinoma (mRCC).” View full resource at empr.com
Most Recently Shared on October 7, 2010 at 9:54 pm By:
MPR News: Phase 2 study of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC): Argos Therapeutics... http://bit.ly/csMsG0
Targeted agents changing treatment of metastatic renal cell carcinoma | HemOncToday
hemonctoday.com — “More than 200,000 people around the world were diagnosed with renal cell carcinoma in 2007, and approximately one-third of those presented with met” View full resource at hemonctoday.com
Most Recently Shared on July 21, 2009 at 3:31 pm By:
Kidney Cancer Health Executive
Targeted agents changing treatment of metastatic renal cell carcinoma http://bit.ly/2l85Rt
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
Michael Fisch
Dept of General Oncology, M.D. Anderson Cancer Center. Tweeting on community/academic oncology, cancer symptoms and side effects, QOL, survivorship, and EOL.
-
Org Wisdom
Health Wisdom from health and healthy living organizations and sources that use Twitter to share health info, links, resources, and research to help people.
Advertisement
